STOCK TITAN

[6-K] Alpha Tau Medical Ltd. Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

Alpha Tau Medical Ltd. (DRTS) furnished a Form 6-K noting it issued a press release titled “Alpha Tau Announces Receipt of Radioactive Material License at New Hampshire Manufacturing Facility.”

The submission states the information is being furnished, not deemed filed, and includes the press release as Exhibit 99.1 dated October 21, 2025.

Alpha Tau Medical Ltd. (DRTS) ha presentato una Form 6-K indicando di aver emesso un comunicato stampa intitolato “Alpha Tau Annuncia il rilascio della licenza per materiale radioattivo presso l'impianto di produzione del New Hampshire.”

La presentazione dichiara che l'informazione è fornita, non archiviata come deposito, e include il comunicato stampa come Exhibit 99.1 datato 21 ottobre 2025.

Alpha Tau Medical Ltd. (DRTS) presentó un Formulario 6-K señalando que emitió un comunicado de prensa titulado “Alpha Tau Anuncia la Recepción de Licencia de Material Radiactivo en la Instalación de Manufactura de New Hampshire.”

La presentación indica que la información se está proporcionando, no se considera presentada, y adjunta el comunicado de prensa como Exhibit 99.1 con fecha 21 de octubre de 2025.

Alpha Tau Medical Ltd. (DRTS)은 Form 6-K를 제출했으며, “Alpha Tau는 뉴햄프셔 제조 시설에서 방사성 물질 라이선스 취득 발표”라는 제목의 보도자료를 발표했다고 명시했습니다.

제출은 정보가 제공되는 것이며 보관된 것으로 간주되지 않는다고 명시하고, 보도자료를 Exhibit 99.1로 2025년 10월 21일자로 포함하고 있습니다.

Alpha Tau Medical Ltd. (DRTS) a fourni un formulaire 6-K indiquant qu'il a publié un communiqué intitulé « Alpha Tau annonce l'obtention d'une licence de matériel radioactif à l'installation de fabrication du New Hampshire ».

La soumission précise que l'information est fournie et non déposée, et inclut le communiqué de presse en tant que Exhibit 99.1 daté du 21 octobre 2025.

Alpha Tau Medical Ltd. (DRTS) hat ein Formular 6-K vorgelegt und mitgeteilt, dass eine Pressemitteilung mit dem Titel „Alpha Tau announces receipt of radioactive material license at New Hampshire manufacturing facility“ veröffentlicht wurde.

Die Einreichung gibt an, dass die Informationen bereitgestellt werden und nicht als eingereicht gelten, und schließt die Pressemitteilung als Exhibit 99.1 mit dem Datum 21. Oktober 2025 ein.

Alpha Tau Medical Ltd. (DRTS) قدّمت نموذج 6-K مُبيّنة أنها أصدرت بياناً صحافياً بعنوان “Alpha Tau Announces Receipt of Radioactive Material License at New Hampshire Manufacturing Facility.”

تشير الإقامة إلى أن المعلومات تُقدَّم، ولا تعتبر كملف مُودع، وتتضمن البيان الصحفي كـ Exhibit 99.1 المؤرّخ 21 أكتوبر 2025.

Alpha Tau Medical Ltd. (DRTS) 已提交 Form 6-K,指出其发布了一则题为“Alpha Tau Announces Receipt of Radioactive Material License at New Hampshire Manufacturing Facility.”的新闻稿。

该提交声明信息正在提供中,并不视为已备案,与新闻稿作为Exhibit 99.1,日期为2025年10月21日。

Positive
  • None.
Negative
  • None.

Alpha Tau Medical Ltd. (DRTS) ha presentato una Form 6-K indicando di aver emesso un comunicato stampa intitolato “Alpha Tau Annuncia il rilascio della licenza per materiale radioattivo presso l'impianto di produzione del New Hampshire.”

La presentazione dichiara che l'informazione è fornita, non archiviata come deposito, e include il comunicato stampa come Exhibit 99.1 datato 21 ottobre 2025.

Alpha Tau Medical Ltd. (DRTS) presentó un Formulario 6-K señalando que emitió un comunicado de prensa titulado “Alpha Tau Anuncia la Recepción de Licencia de Material Radiactivo en la Instalación de Manufactura de New Hampshire.”

La presentación indica que la información se está proporcionando, no se considera presentada, y adjunta el comunicado de prensa como Exhibit 99.1 con fecha 21 de octubre de 2025.

Alpha Tau Medical Ltd. (DRTS)은 Form 6-K를 제출했으며, “Alpha Tau는 뉴햄프셔 제조 시설에서 방사성 물질 라이선스 취득 발표”라는 제목의 보도자료를 발표했다고 명시했습니다.

제출은 정보가 제공되는 것이며 보관된 것으로 간주되지 않는다고 명시하고, 보도자료를 Exhibit 99.1로 2025년 10월 21일자로 포함하고 있습니다.

Alpha Tau Medical Ltd. (DRTS) a fourni un formulaire 6-K indiquant qu'il a publié un communiqué intitulé « Alpha Tau annonce l'obtention d'une licence de matériel radioactif à l'installation de fabrication du New Hampshire ».

La soumission précise que l'information est fournie et non déposée, et inclut le communiqué de presse en tant que Exhibit 99.1 daté du 21 octobre 2025.

Alpha Tau Medical Ltd. (DRTS) hat ein Formular 6-K vorgelegt und mitgeteilt, dass eine Pressemitteilung mit dem Titel „Alpha Tau announces receipt of radioactive material license at New Hampshire manufacturing facility“ veröffentlicht wurde.

Die Einreichung gibt an, dass die Informationen bereitgestellt werden und nicht als eingereicht gelten, und schließt die Pressemitteilung als Exhibit 99.1 mit dem Datum 21. Oktober 2025 ein.

 

  

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 6-K

 

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO SECTION 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of October 2025

 

Commission File Number: 001-41316

 

 

 

Alpha Tau Medical Ltd.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Kiryat HaMada St. 5

Jerusalem, Israel 9777605

+972 (3) 577-4115

(Address of principal executive offices)

 

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☒            Form 40-F  

 

 

 

  

 

CONTENTS

 

On October 21, 2025, Alpha Tau Medical Ltd. (the “Company”) issued a press release titled “Alpha Tau Announces Receipt of Radioactive Material License at New Hampshire Manufacturing Facility.” A copy of this press release is attached to this Form 6-K as Exhibit 99.1.

 

The information in this Report on Form 6-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise set forth herein or as shall be expressly set forth by specific reference in such a filing.

 

1

 

 

EXHIBIT INDEX

 

Exhibit No.   Description
   
99.1   Press release dated October 21, 2025.

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Alpha Tau Medical Ltd.
     
Date: October 21, 2025 By:  /s/ Uzi Sofer
    Uzi Sofer
    Chief Executive Officer

 

 

3

 

 

Alpha Tau Medical Ltd

NASDAQ:DRTS

DRTS Rankings

DRTS Latest News

DRTS Latest SEC Filings

DRTS Stock Data

357.18M
57.16M
32.79%
2.28%
0.11%
Biotechnology
Healthcare
Link
Israel
Jerusalem